$4.12
▼ -2.8% Today
as of Oct 23, 09:21 ET
Last 30 days
Recent Press Releases & News
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
PBM earnings at a glance
The share price of $4.12 sits near its 52-week low.
Overview
52-week range
$1.92
$134
2% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for PBM.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.